The DOHH/eIF5A pathway, crucial for nerve regeneration, underscores DOHH’s potential as a therapeutic target for ischemic neuronal injury, despite the lack of selective small molecule DOHH activators for stroke therapy to date. This evidence concerns the gene DOHH and stroke disorder.